CVS Health Corp (CVS)
62.10
+0.00 (0.00%)
NYSE · Last Trade: Aug 1st, 5:38 AM EDT
Detailed Quote
Previous Close | 62.10 |
---|---|
Open | - |
Bid | 61.50 |
Ask | 61.98 |
Day's Range | N/A - N/A |
52 Week Range | 43.56 - 72.51 |
Volume | 9,842 |
Market Cap | 81.95B |
PE Ratio (TTM) | 17.30 |
EPS (TTM) | 3.6 |
Dividend & Yield | 2.660 (4.28%) |
1 Month Average Volume | 8,656,887 |
Chart
About CVS Health Corp (CVS)
CVS Health Corp is a diversified healthcare company that operates a vast network of retail pharmacies, providing prescription medications, over-the-counter products, and health and wellness services. In addition to its retail operations, CVS Health also offers pharmacy benefit management services, helping manage prescription drug costs for businesses and health plans. The company is involved in providing health insurance and health services through its various divisions, including a growing presence in digital health solutions and immunization services. By integrating pharmacy services with healthcare delivery, CVS Health aims to enhance patient care and improve health outcomes across the communities it serves. Read More
News & Press Releases
Mark Cuban challenges the idea that high drug prices are necessary for R&D, PBMs take away from profits, leaving less for innovation.
Via Benzinga · August 1, 2025
A post-earnings surge in Meta Platforms Inc. (NASDAQ:META) and Microsoft Corp.
Via Benzinga · July 31, 2025
Discover the S&P500 stocks that are experiencing unusual trading volume in today's session. Find out more about these stocks below.
Via Chartmill · July 31, 2025
The firm now expects full-year adjusted earnings per share of $6.30 to $6.40, up from its previous guidance of $6.00 to $6.20.
Via Stocktwits · July 31, 2025
Looking for opportunities in today's market? Check out the S&P500 gap up and gap down stocks on Thursday and stay ahead of the market trends.
Via Chartmill · July 31, 2025
CVS Health reported strong Q2 results with revenue and adjusted earnings surpassing estimates and raised its full-year 2025 guidance.
Via Benzinga · July 31, 2025
Stay updated with the S&P500 stocks that are on the move in today's pre-market session.
Via Chartmill · July 31, 2025
Diversified healthcare company CVS Health (NYSE:CVS) reported Q2 CY2025 results topping the market’s revenue expectations, with sales up 8.4% year on year to $98.92 billion. Its non-GAAP profit of $1.81 per share was 23.9% above analysts’ consensus estimates.
Via StockStory · July 31, 2025
CVS Health beats Q2 earnings and revenue estimates, raising full-year guidance. Shares surge 7% pre-market on strong Aetna and CVS Caremark performance.
Via Chartmill · July 31, 2025
Via Benzinga · July 31, 2025
Let's delve into the developments on the US markets one hour before the close of the markets on Wednesday. Below, you'll find the top gainers and losers within the S&P500 index during today's session.
Via Chartmill · July 30, 2025
Let's have a look at the top S&P500 gainers and losers in the middle of the day of today's session.
Via Chartmill · July 30, 2025
The US market is yet to commence its session on Wednesday, but let's get a preview of the pre-market session and explore the top S&P500 gainers and losers driving the early market movements.
Via Chartmill · July 30, 2025
Diversified healthcare company CVS Health (NYSE:CVS)
will be reporting earnings this Thursday before market hours. Here’s what to expect.
Via StockStory · July 29, 2025
Benzinga examined the prospects for many investors' favorite stocks over the last week — here's a look at some of our top stories.
Via Benzinga · July 26, 2025
Molina Healthcare missed Q2 EPS estimates and lowered its 2025 guidance, pressuring major health insurers including UnitedHealth and Centene.
Via Benzinga · July 24, 2025
From novel pharmaceuticals to telemedicine, most healthcare companies are on a mission to drive better patient outcomes. But speed bumps such as inventory destockings have persisted in the wake of COVID-19,
and over the past six months, the industry has pulled back by 11.9%. This performance is a stark contrast from the S&P 500’s 4.3% gain.
Via StockStory · July 24, 2025
Via Benzinga · July 21, 2025
Momentum in medical and tech-focused small caps continues to explode, led by
Via AB Newswire · July 15, 2025
Synergy CHC Corp. (NASDAQ: SNYR) is capturing national attention with the announcement of a strategic distribution partnership with McKesson Canada, a division of McKesson Corporation (NYSE: MCK) . The agreement gives FOCUSfactor® direct access to thousands of pharmacies and health-focused retailers across Canada, igniting the next phase of its aggressive North American expansion.
Via AB Newswire · July 14, 2025
Backed by $1 million in funding from the CVS Health Foundation, the pilot initiative offers free, virtual health screenings to support aging with confidence, care, and convenience Health checks include assessments for heart health, memory, cognitive function, and mental health No travel required — all appointments are virtual and confidential Community Health Workers provide […]
Via FinancialNewsMedia · July 10, 2025
EQNX::TICKER_START (OTCQB:TREIF),(CSE:TRUE),(NYSE:CVS),(NYSE:TDOC),(NASDAQ:TEM),(NYSE:HIMS) EQNX::TICKER_END
Via FinancialNewsMedia · July 10, 2025
PALM BEACH, Fla., July 10, 2025 (GLOBE NEWSWIRE) -- FN Media Group News Commentary - The global telehealth market has been substantially growing over the past years and is expected to continue this growth well into the future. A report from Grand View Research said that: “The global telehealth market size was estimated at USD 123.26 billion in 2024 and is projected to reach USD 455.27 billion by 2030, growing at a CAGR of 24.68% from 2025 to 2030. North America dominated the telehealth market with the revenue share of 46.58% in 2024. The market is primarily driven by the increasing adoption of digital health & smartphones, rising investments, improved internet connectivity, and growing technological advancements… the growing adoption and acceptance of telehealth services are expected to boost the market's growth over the forecast period.” The report continued: “Moreover, smartphones have evolved from devices of communication & entertainment to devices that can monitor health and fitness. Some market players are developing Chatbot services for basic medical inquiries and one-time consultations… Moreover, the market is propelled by favorable government initiatives to expand telehealth by making healthcare services more accessible and convenient for patients. The focus on cost-effective and efficient healthcare solutions further propels the adoption of telehealth services. The rising adoption of telehealth facilities by patients, physicians, and government authorities is boosting the market. Access to healthcare through specific applications and video consultations enables communication between patients and doctors in remote locations, eliminating the need to visit hospitals or clinics. Market players such as Apple, Google, and IBM focus on improving the mobile health experience by providing numerous solutions through different subscription plans and emphasizing data security. These factors are expected to drive the market growth over the forecast period.” Active tech companies in the markets this week include Treatment AI, Inc. (OTCQB: TREIF) (CSE: TRUE), CVS Health® (NYSE: CVS), Teladoc Health, Inc. (NYSE: TDOC), Tempus AI, Inc. (NASDAQ: TEM), Hims & Hers Health, Inc. (NYSE: HIMS).
By FN Media Group LLC · Via GlobeNewswire · July 10, 2025